33709-7Clostridium botulinum toxin A [Presence] in SpecimenActive
Part Description
LP31258-4 Clostridium botulinum toxin A
Botulinum toxin is a neurotoxin produced by Clostridium botulinum, an anaerobic, gram-positive, spore-forming rod found on plants, in soil, water and the intestinal tracts of animals. Eight exotoxins (A, B, C1, C2, D, E, F and G) have been identified, all of which interfere with neural transmission by blocking the release of acetylcholine, the principal neurotransmitter at the neuromuscular junction. The toxins are used in the clinical management of various spastic medical conditions, strabismus and focal dystonias, hemifacial spasms, headaches, hyper-salivation and hyperhidrosis. Type A is the most potent toxin. In 2002 it was approved by the U.S. Food and Drug Administration for cosmetological uses. It is administered by injection into muscles or glands with the effects lasting approximately three months. Most patients require multiple treatments over many years and some develop tolerance to the injections due to the development of neutralizing antibodies to the toxin. Side effects are minor and transient. [PMID:20418969]
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Clostridium botulinum toxin A
- Property
- PrThr
- Time
- Pt
- System
- XXX
- Scale
- Ord
- Method
Additional Names
- Short Name
- C bot Tox A Spec Ql
- Display Name
- C. botulinum toxin A Ql (Specimen)
- Consumer Name Alpha
- Clostridium botulinum toxin A, Specimen
Example Answer List LL360-9
Source: Regenstrief Institute
Answer | Code | Score | Answer ID |
---|---|---|---|
Positive Copyright http://snomed.info/sct ID:10828004 Positive (qualifier value) | LA6576-8 | ||
Negative Copyright http://snomed.info/sct ID:260385009 Negative (qualifier value) | LA6577-6 |
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.09
- Last Updated
- Version 2.69
- Change Reason
- Changed answer list from "Normative" to "Example" to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
- Order vs. Observation
- Both
Member of these Groups
LG41628-5 | Clostridium botulinum |
Language Variants Get Info
- zh-CNChinese (China)
- 肉毒梭菌毒素 A:
存在情况或阈值: 时间点: XXX: 序数型: - nl-NLDutch (Netherlands)
- Clostridium botulinum toxine A:
aanwezigheid: moment: XXX: ordinaal: - et-EEEstonian (Estonia)
- Clostridium botulinum toksiin A:
PrThr: Pt: XXX: Ord: - fr-BEFrench (Belgium)
- Toxine Clostridium botulinum A:
PrThr: Temps ponctuel: XXX: Ordinal: - fr-CAFrench (Canada)
- Toxine Clostridium botulinum A:
Présence-Seuil: Temps ponctuel: XXX: Ordinal: - fr-FRFrench (France)
- Clostridium botulinum toxine A:
Présence/Seuil: Ponctuel: Milieux divers: Qualitatif: - de-DEGerman (Germany)
- Clostridium botulinum Toxin A:
Nachweis oder Schwellenwert: Zeitpunkt: XXX: Ordinal: - it-ITItalian (Italy)
- Clostridium botulinum, tossina A:
PrThr: Pt: XXX: Ord: - ko-KRKorean (Korea, Republic of)
- 클로스트리디움 보튤리늄 독소 A:
임의농도: 검사시점: XXX: 순위척도: - pt-BRPortuguese (Brazil)
- Clostridium botulinum toxina A:
ACnc: Pt: XXX: Ord: - ru-RURussian (Russian Federation)
- Clostridium botulinum токсин A:
PrThr: ТчкВрм: XXX: Пор: - es-ARSpanish (Argentina)
- toxina de Clostridium botulinum A:
concentración arbitraria: punto en el tiempo: XXX: ordinal: - es-MXSpanish (Mexico)
- Toxina A de Clostridium botulinum:
Presencia o umbral: Punto temporal: XXX: Ordinal: - es-ESSpanish (Spain)
- Toxina A del Clostridium botulinum:
PrThr: Punto temporal: XXX: Ord: - tr-TRTurkish (Turkey)
- Clostridium botulinum toksin A:
MevcEşik: Zmlı: XXX: Srl:
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=33709-7
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright